Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Congenital Adrenal Hyperplasia
CYP21 polymorphisms are plausible disease-causing mutations in CAH patients
September 8th, 2005
Steroid 21-hydroxylase (CYP21) polymorphisms are plausible disease-causing mutations in congenital adrenal hyperplasia patients with a mild form of the disease. In a recent article published in the European Journal Of Endocrinology, scientists in Slovenia conducted a study "To analyze the mutational spectrum of CYP21 and the genotype-phenotype correlation in patients with congenital adrenal hyperplasia (CAH) registered in the Middle European Society for Pediatric Endocrinology CAH database, and to design a reliable and rational approach for CYP21 mutation detection in Middle European populations." V. Dolzan and associates at the University of...
Source: Women's Health Weekly (2005-09-08)
|
